Venous Thromboembolism Risk Following Total Joint Arthroplasty in Rheumatoid Arthritis Patients Treated with Janus Kinase Inhibitors Versus Tumor Necrosis Factor Inhibitors: A Propensity Score-Matched Cohort Study
Sep 2026· Journal of Clinical Medicine· Vol 15, pp. 7098· 0 citations· 21 references
Medicine
TL;DR
Among RA patients undergoing primary TJA, JAK inhibitor use was not associated with a statistically significant increase in postoperative VTE compared with TNF inhibitor use, although VTE events occurred numerically more often in the JAK inhibitor cohort.
Abstract
Background: Janus kinase (JAK) inhibitors have been linked to higher venous thromboembolism (VTE) rates than tumor necrosis factor (TNF) inhibitors in rheumatoid arthritis (RA) populations, yet it is uncertain whether this risk extends postoperatively after total joint arthroplasty (TJA). Methods: A retrospective propensity score-matched cohort study was performed using a large federated network of de-identified electronic health records. Adults with RA undergoing primary total knee or hip arthroplasty were identified, and patients were categorized based on the use of a JAK inhibitor or a TNF inhibitor within 3 months of surgery. Propensity score matching was conducted in a 1:1 ratio based on demographics, comorbidities, and medications. The primary outcome was VTE, defined as deep vein thrombosis or pulmonary embolism occurring from postoperative day 1 through 365 days; patients with VTE prior to this window were excluded. Results: Before matching, 305 JAK inhibitor users and 1299 TNF inhibitor users met inclusion criteria; after propensity score matching, 304 patients remained in each cohort, and exclusion of patients with prior VTE yielded 284 JAK inhibitor users and 288 TNF inhibitor users for analysis. VTE occurred in 17 JAK inhibitor users (6.0%) and 11 TNF inhibitor users (3.8%), corresponding to a risk ratio of 1.57 (95% confidence interval [CI], 0.75–3.29; p = 0.230). Kaplan–Meier analysis demonstrated a hazard ratio of 1.56 (95% CI, 0.73–3.33), with no statistically significant difference between groups (log-rank p = 0.248). Conclusions: Among RA patients undergoing primary TJA, JAK inhibitor use was not associated with a statistically significant increase in postoperative VTE compared with TNF inhibitor use, although VTE events occurred numerically more often in the JAK inhibitor cohort. These findings do not exclude a clinically relevant increase in postoperative thrombotic risk with JAK inhibitors, and larger studies are required to clarify the magnitude of risk and to inform thromboprophylaxis strategies.
Abstract Objectives: To evaluate the impact of estrogen hormone therapy on venous thrombotic events for femoral neck fractures treated with either total hip arthroplasty (THA) or hemiarthroplasty (HA). Methods: Design: Retrospective cohort analysis. Setting: TriNetX Health Research Network. Patient Selection Criteria:...
Andrew Ni, Lana Abdelrahim, Casey D. McDonald et al.· OTA International· 0 citations
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed for glycemic control and weight management, but their association with postoperative thrombotic events after total knee arthroplasty (TKA) remains unclear. We performed a retrospective cohort study using de-identified data from t...
Bryan Yavari, Aria Soltankhah, Nafis B. Eghrari et al.· The journal of knee surgery· 0 citations
BACKGROUND
Studies comparing aspirin with anticoagulants for venous thromboembolism (VTE) prophylaxis after total hip or knee arthroplasty have had conflicting results.
METHODS
In a comparative-effectiveness noninferiority trial, we randomly assigned patients undergoing elective hip or knee arthroplasty to receive as...
V. D. Pellegrini, Carol A. Lambourne, L. Magder et al.· New England Journal of Medic...· 0 citations
PURPOSE
To determine the real-world clinical practice incidence and predictive factors of venous and arterial thromboembolic events (VTE/ATE) in lung cancer patients treated with osimertinib.
METHODS/PATIENTS
A multicenter retrospective study including 546 lung cancer patients who initiated treatment with osimertinib...
Manuel Sánchez Cánovas, Javier López Robles, C. Fernandez-Reino et al.· Clinical and Translational O...· 0 citations
BACKGROUND
Nonsteroidal anti-inflammatory drugs (NSAIDs), particularly selective cyclooxygenase-2 (COX-2) inhibitors, are foundational to multimodal pain management following primary total-hip arthroplasty (THA) but concerns regarding bleeding often limit their use in patients receiving chronic anticoagulation. While d...
Sri Tummala, Angel A. Valencia, Antonia F. Chen et al.· Journal of Arthroplasty· 0 citations
The main pooled analyses associated aspirin-based thromboprophylaxis with higher risks of symptomatic thromboembolic events, however, the symptomatic DVT and symptomatic VTE associations were no longer statistically significant after exclusion of CRISTAL or restriction to trials at low risk of bias.
Hasan Al-Chalabi, Omar Amro, Amy Gordon et al.· Medicina· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.